Tag: CDH1

Newsletter Fall 2021

Updates to NCCN Genetic/Familial High-Risk Assessment

Breast, Ovarian, and Pancreatic Guidelines V.1.2022: Released August 11th, 2021 Colorectal Cancer Guidelines V.1.2021: Released May 11th, 2021 Check out the full NCCN guidelines by creating a FREE account at www.nccn.org

Permanent link to this article: https://inheritedcancer.net/newsletter-fall-2021-updates-to-nccn-genetic-familial-high-risk-assessment/

ICARE Social Media Post January 2022

Gastric Cancer Risks: CDH1

Read the ๐˜‘๐˜ˆ๐˜”๐˜ˆ ๐˜š๐˜ถ๐˜ณ๐˜จ๐˜ฆ๐˜ณ๐˜บ article to learn morehttps://jamanetwork.com/journals/jamasurgery/article-abstract/2785097Reference: Gamble et al. JAMA Surg. 2021 Oct 13;e215118. PMID: 34643667.

Permanent link to this article: https://inheritedcancer.net/post11122/

ICARE Social Media Post August 2021

Metastatic Breast Cancer Genes

For additional information, read the Journal of Clinical Oncology article at the link below ๐Ÿ‘‡ https://ascopubs.org/doi/10.1200/JCO.20.01200

Permanent link to this article: https://inheritedcancer.net/post82021/

ICARE Social Media Post August 2021

Breast Cancer Risk Among Breast Cancer Gene Carriers Varies by Polygenic Risk Score

For more information, read the ๐˜‘๐˜ฐ๐˜ถ๐˜ณ๐˜ฏ๐˜ข๐˜ญ ๐˜ฐ๐˜ง ๐˜Š๐˜ญ๐˜ช๐˜ฏ๐˜ช๐˜ค๐˜ข๐˜ญ ๐˜–๐˜ฏ๐˜ค๐˜ฐ๐˜ญ๐˜ฐ๐˜จ๐˜บ article at the link below:https://ascopubs.org/doi/figure/10.1200/JCO.20.01992

Permanent link to this article: https://inheritedcancer.net/post81321/

ICARE Social Media Post June 2021

A Population-Based Study of Genes Previously Implicated in Breast Cancer

For additional information, read the article at the following link: https://www.nejm.org/doi/10.1056/NEJMoa2005936

Permanent link to this article: https://inheritedcancer.net/post62521/

ICARE Social Media Post March 2021

Three Articles: Breast Cancer Risks

For additional information about the: ใ€‹US-based study, visit: https://www.nejm.org/doi/full/10.1056/nejmoa2005936 ใ€‹International study, visit: https://www.nejm.org/doi/full/10.1056/nejmoa1913948 ใ€‹Accompanying editorial: https://www.nejm.org/doi/full/10.1056/NEJMe2035083

Permanent link to this article: https://inheritedcancer.net/post30921/

ICARE Social Media Post December 2020

CDH1 Cancer Risks

When a ๐˜พ๐˜ฟ๐™ƒ1 mutation is identified, several factors should be considered to figure out what the cancer risks might be and what medical management should be advised. Specifically, differences in cancer risks among those with a ๐˜พ๐˜ฟ๐™ƒ1 mutation are not well understood.   Identifying a ๐˜พ๐˜ฟ๐™ƒ1 mutation in families with hereditary diffuse gastric cancer (HDGC) …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post121520/

ICARE Social Media Post October 2020

CDH1: Cancer Risks and Risk Management

Gene: ๐˜พ๐˜ฟ๐™ƒ๐Ÿญ Cancer Risks and Management per NCCN Genetic/Familial High-Risk Assessment: Breast/Ovarian/Pancreatic Version 1.2021 and Gastric Version 3.2020: ๐—ช๐—ผ๐—บ๐—ฒ๐—ป: Breast cancer risk: Elevated at 55% – Recommend annual mammogram starting at age 30; consider breast MRI with contrast starting at age 30. ๐— ๐—ฒ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—ช๐—ผ๐—บ๐—ฒ๐—ป: Stomach cancer risk: Elevated at 83% for women, and 67% …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post103020/

ICARE Social Media Post August 2020

Optimal Timing of Prophylactic Gastrectomy for CDH1 Carriers

Individuals with a CDH1 mutation and classic personal and family history of diffuse gastric (stomach) cancer have a very high risk of developing and dying from stomach cancer, if they do not have preventive surgery to remove their stomach. A simulation study to assess prophylactic total gastrectomy (PTG; the removal of the stomach to prevent …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post82120/

ICARE Social Media Post July 2020

BRCA1/2 and Other Gene Carriers with Breast Cancer Donโ€™t Always Receive Recommended Treatment

BRCA1/2 and other gene mutation carriers with early stage breast cancer are not always receiving cancer treatment as recommended by national guidelines. Even though more and more people have been tested for hereditary cancer over the years, using this information accurately to guide treatment has not been as successful. These findings highlight the need for …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post71020/

ICARE Social Media Post May 2020

CDH1: Gastric and Breast Cancer Risks

CDH1 mutation carriers are at higher risk for diffuse gastric cancer (men and women) and lobular breast cancer (women). Current strategies to manage high risks of gastric cancer include prophylactic gastrectomy (i.e., removal of the stomach), which can have severe physical and psychological implications. A recent study found that men have a higher risk of …

Continue reading

Permanent link to this article: https://inheritedcancer.net/post50520/

ICARE Newsletter Summer 2015

2015 NCCN Clinical Practice Guideline Update

Breast and Ovarian Management Based on Genetic Test Resultsa   Recommend Breast MRIc (>20% lifetime risk of breast cancerd) Recommend Risk-reducing salpingo-oophorectomy Discuss Option of Risk-reducing mastectomy Intervention warranted based on gene and/or risk level ATM, BRCA1, BRCA2, CDH1, CHEK2, PALB2, PTEN, STK11, TP53 BRCA1, BRCA2, Lynch syndromee BRCA1, BRCA2, CDH1, PTEN, TP53 Insufficient evidence …

Continue reading

Permanent link to this article: https://inheritedcancer.net/1nls2015/